Table 1.
1. The efficacy of BCG is 50% |
2. The duration of BCG efficacy is 10–15 years |
3. BCG prevents disseminated tuberculosis and tuberculous meningitis but not pulmonary tuberculosis |
4. BCG is ineffective in southern latitudes due to high background rates of infection with non-tuberculous mycobacteria |
5. Live BCG is the only vaccine against tuberculosis to have shown efficacy in humans |
6. New vaccines against tuberculosis should be based exclusively on antigens from Mycobacterium tuberculosis |